Stocks · Health care · Pharmaceutical Preparations

Spyre Therapeutics, Inc.

SYRE Clue Score15

United States Fiscal year ends December CIK 0001636282 Results filed 3 Nov 2026

Add to watchlist

What the insiders did Mostly scheduled

Bought (120 mo)

$4.00M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$445.49M

$21.21M on a plan · $422.03M straight out of an exercise

Sold at will

$2.25M

9 of 107 sales

Net

−$441.49M

+$1.75M against sales at will